F-star Biotechnology Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From F-star Biotechnology Limited
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
Huge economic shock to sector could be quickly alleviated by early payment of R&D Tax Credits, says BIA.
Two years after its first big Navacim-based tie-up with Novartis, Parvus could earn beyond $800m in autoimmune R&D pact with Genentech. Iconic licenses ADC tech from Zymeworks, then out-licenses lead candidate to Exelixis.
Ghent, Belgium-based start-up, AgomAb Therapeutics NV secures funds and license to develop HGF-mimetic agonistic monoclonal antibodies for regeneration of damaged tissues.
- Drug Discovery Tools
- Other Names / Subsidiaries
- F-star Alpha Ltd.
- F-star GmbH
- F-star Therapeutics